Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
В этом разделе статьи показаны на английском.
Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Редакция Trade News (2026-11-09) фиксирует рынок: Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity. Первоисточник — оригинал CNBC Top News (cnbc.com).
Читайте также
A failed trial for a heart drug casts shadow over rivals developing similar therapies
